diabetic microangiopathy

diabetic microangiopathy

Microvascular disease Any clinical or pathological changes resulting from small vessel disease in PTs with DM Measurement Capillary HTN can be measured directly by microcannulation of nailfold capillaries with a glass micropipette Prognosis Progression can be slowed by tight control of serum glucose levels, especially with long-term intense insulin therapy
References in periodicals archive ?
The association between paraoxonase 1 activity and the susceptibilities of diabetes mellitus, diabetic macroangiopathy and diabetic microangiopathy. J Cell Mol Med.
Another outcome of oxidative stress is the advanced glycation end-products, which are free radicals resulting diabetic microangiopathy, a widespread complication caused by endothelial dysfunction (Vlassara, 1996).
(71, 72) In humans, a lecithinized curcumin delivery system assisted with the management of diabetic microangiopathy and retinopathy.
Cochlear dysfunction and diabetic microangiopathy. Scand Audiol Suppl 2001;(52):199-203.
Tezza et al., "Regenerative therapies for diabetic microangiopathy," Experimental Diabetes Research, vol.
Diabetic microangiopathy is an independent predictor of incident diabetic foot ulcer.
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study.
Our study was designed to investigate a potential relationship between specific biomarkers of oxidation, glycation, and glycoxidation in diabetic patients and whether they could be associated with vascular complications related to diabetic microangiopathy and macroangiopathy.
Adamiec, "Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy," Acta Diabetologica, vol.
Other factors implicated in the pathogenesis are hypoxic injury to capillary and alveolar membrane, mechanical stress, and decreased surfactants.[sup][3] Recently, diabetes mellitus has been found to be an independent risk factor for the development of RPE in patients with spontaneous pneumothorax.[sup][5] Diabetic microangiopathy is the fundamental pathophysiological abnormality that results in several end-organ damage in diabetes.
(14) Diabetic cheiroarthropathy, that may develop due to the changes in collagen biochemistry and diabetic microangiopathy of the skin, tends to respond well to physical therapy.
There is debate about the exact etiology of diabetic muscle infarction but several theories have been postulated such as vasculitis, thrombosis of small vessels, atherosclerotic plaquing, and diabetic microangiopathy. (3,4) Another proposed mechanism is activation of the coagulation cascade due to alteration in coagulation-fibrinolytic pathway as described by Palmer and Grees.